Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1.35 Million - $1.65 Million
30,935 Added 142.71%
52,612 $2.3 Million
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $1.64 Million - $1.94 Million
-35,143 Reduced 61.85%
21,677 $1.14 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $5,169 - $6,405
-113 Reduced 0.2%
56,820 $2.94 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $67,640 - $100,266
1,637 Added 2.96%
56,933 $3.36 Million
Q3 2021

Dec 10, 2021

BUY
$39.25 - $50.42 $37,994 - $48,806
968 Added 1.78%
55,296 $11,000
Q2 2021

Aug 03, 2021

BUY
$35.91 - $40.68 $62,591 - $70,905
1,743 Added 3.31%
54,328 $2.13 Million
Q1 2021

Apr 12, 2021

BUY
$33.49 - $37.77 $145,212 - $163,770
4,336 Added 8.99%
52,585 $1.91 Million
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $127,085 - $161,600
3,797 Added 8.54%
48,249 $1.78 Million
Q3 2020

Oct 13, 2020

BUY
$31.75 - $37.25 $165,639 - $194,333
5,217 Added 13.3%
44,452 $1.63 Million
Q2 2020

Jul 27, 2020

BUY
$30.12 - $36.54 $95,871 - $116,306
3,183 Added 8.83%
39,235 $1.28 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $499,433 - $713,581
-18,477 Reduced 33.88%
36,052 $1.37 Million
Q4 2019

Feb 04, 2020

BUY
$32.92 - $37.36 $196,828 - $223,375
5,979 Added 12.32%
54,529 $2.17 Million
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $479,584 - $621,880
14,761 Added 43.69%
48,550 $1.74 Million
Q2 2019

Jul 12, 2019

BUY
$36.98 - $41.52 $38,237 - $42,931
1,034 Added 3.16%
33,789 $1.48 Million
Q1 2019

May 09, 2019

BUY
$37.5 - $41.2 $1.23 Million - $1.35 Million
32,755 New
32,755 $1.39 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Jackson Wealth Management, LLC Portfolio

Follow Jackson Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Wealth Management, LLC with notifications on news.